![]() |
![]() |
|
||||||
|
||
| HOME > Online Resources | ||
|
Online ResourcesLearning about your condition is an important part of taking an active role in your treatment. The Internet may provide helpful information about bipolar disorder, such as www.1on1health.com. Be sure to discuss all information related to your condition and treatment with your healthcare provider. For additional information, please visit these sites or contact these organizations. The Web sites listed are external to GlaxoSmithKline. GlaxoSmithKline does not have control over the content of the information provided on these Web sites and therefore does not warrant their accuracy and completeness.
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Important Safety Information About LAMICTAL® (lamotrigine) Tablets and LAMICTAL® ODT™ (lamotrigine) Orally Disintegrating TabletsLAMICTAL may cause a serious skin rash that may cause you to be hospitalized or to stop LAMICTAL; it may rarely cause death. There is no way to tell if a mild rash will develop into a more serious reaction. These serious skin reactions are more likely to happen when you begin taking LAMICTAL, within the first 2-8 weeks of treatment. But it can happen in people who have taken LAMICTAL for any period of time. Children between 2 to 16 years of age have a higher chance of getting this serious skin reaction while taking LAMICTAL. The risk of getting a rash is higher if taking LAMICTAL while taking valproate [Depakene* (valproic acid) or Depakote* (divalproex sodium)], taking a higher starting dose of LAMICTAL than a healthcare provider prescribed or increasing the dose of LAMICTAL faster than prescribed. LAMICTAL can also cause other types of allergic reactions or serious problems which may affect organs and other parts of your body like the liver or blood cells. You may or may not have a rash with these types of reactions. Call your healthcare provider right away if you have any of the following: a skin rash, hives, fever, swollen lymph glands, painful sores in the mouth or around your eyes, swelling of your lips or tongue, yellowing of your skin or eyes, unusual bruising or bleeding, severe fatigue or weakness, severe muscle pain or frequent infections. These symptoms may be the first signs of a serious reaction. A healthcare provider should examine you to decide if you should continue taking LAMICTAL. You should not take LAMICTAL if you have had an allergic reaction to lamotrigine or to any of the inactive ingredients. LAMICTAL may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call a healthcare provider right away if you have worsening depression, any unusual changes in mood or behavior, or thoughts or actions about suicide or self-harm, especially if they are new, worse, or worry you (see Medication Guide). Always check that you receive LAMICTAL or LAMICTAL ODT Patients prescribed LAMICTAL have sometimes been given the wrong medicine because many medicines have names similar to LAMICTAL, so always check that you receive LAMICTAL. Taking the wrong medication can cause serious health problems. When your healthcare provider gives you a prescription for LAMICTAL or LAMICTAL ODT, make sure you can read it clearly. Talk to your pharmacist to check that you are given the correct medicine. Each time you fill your prescription, check the tablets you receive against the pictures of the tablets in the Medication Guide that comes with your prescription. Common side effects include dizziness, headache, blurred or double vision, lack of coordination, sleepiness, nausea, vomiting, insomnia, tremor, rash, fever, abdominal pain, back pain, tiredness, and dry mouth. Tell your healthcare provider about any side effect that bothers you or does not go away. Also, tell your healthcare provider if you have any changes in your menstrual pattern, such as breakthrough bleeding, while taking LAMICTAL and birth control pills. These are not all the possible side effects of LAMICTAL.
|
|
|
This website is funded and developed by GlaxoSmithKline. This site is intended for US residents only. © 1997-2010 GlaxoSmithKline. All Rights Reserved. Legal Notices | Privacy Statement | Medicine Savings | Contact Us |